This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garriga, J.
Right arrow Articles by Graña, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garriga, J.
Right arrow Articles by Graña, X.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2003, p. 5165-5173, Vol. 23, No. 15
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.15.5165-5173.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

CDK9 Is Constitutively Expressed throughout the Cell Cycle, and Its Steady-State Expression Is Independent of SKP2

Judit Garriga,1 Sabyasachi Bhattacharya,1 Joaquim Calbó,1,2 Renée M. Marshall,1 May Truongcao,1 Dale S. Haines,1 and Xavier Graña1*

Fels Institute for Cancer Research and Molecular Biology and Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140,1 Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain2

Received 12 March 2003/ Accepted 2 May 2003

CDK9 is a CDC2-related kinase and the catalytic subunit of the positive-transcription elongation factor b and the Tat-activating kinase. It has recently been reported that CDK9 is a short-lived protein whose levels are regulated during the cell cycle by the SCFSKP2 ubiquitin ligase complex (R. E. Kiernan et al., Mol. Cell. Biol. 21:7956-7970, 2001). The results presented here are in contrast to those observations. CDK9 protein levels remained unchanged in human cells entering and progressing through the cell cycle from G0, despite dramatic changes in SKP2 expression. CDK9 levels also remained unchanged in cells exiting from mitosis and progressing through the next cell cycle. Similarly, the levels of CDK9 protein did not change as cells exited the cell cycle and differentiated along various lineages. In keeping with these observations, the kinase activity associated with CDK9 was found to not be regulated during the cell cycle. We have also found that endogenous CDK9 is a very stable protein with a half-life (t1/2) of 4 to 7 h, depending on the cell type. In contrast, when CDK9 is overexpressed, it is not stabilized and is rapidly degraded, with a t1/2 of less than 1 h, depending on the level of expression. Treatment of cells with proteasome inhibitors blocked the degradation of short-lived proteins, such as p27, but did not affect the expression of endogenous CDK9. Ectopic overexpression of SKP2 led to reduction of p27 protein levels but had no effect on the expression of endogenous CDK9. Finally, downregulation of endogenous SKP2 gene expression by interfering RNA had no effect on CDK9 protein levels, whereas p27 protein levels increased dramatically. Therefore, the SCFSKP2 ubiquitin ligase does not regulate CDK9 expression in a cell cycle-dependent manner.

* Corresponding author. Mailing address: Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, AHP Bldg., Room 308, 3307 North Broad St., Philadelphia, PA 19140. Phone: (215) 707-7416. Fax: (215) 707-5562. E-mail: xavier{at}unix.temple.edu.

Molecular and Cellular Biology, August 2003, p. 5165-5173, Vol. 23, No. 15
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.15.5165-5173.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Sotillo, E., Garriga, J., Padgaonkar, A., Kurimchak, A., Cook, J. G., Grana, X. (2009). Coordinated Activation of the Origin Licensing Factor CDC6 and CDK2 in Resting Human Fibroblasts Expressing SV40 Small T Antigen and Cyclin E. J. Biol. Chem. 284: 14126-14135 [Abstract] [Full Text]  
  • Sotillo, E., Garriga, J., Kurimchak, A., Grana, X. (2008). Cyclin E and SV40 Small t Antigen Cooperate to Bypass Quiescence and Contribute to Transformation by Activating CDK2 in Human Fibroblasts. J. Biol. Chem. 283: 11280-11292 [Abstract] [Full Text]  
  • Krueger, B. J., Jeronimo, C., Roy, B. B., Bouchard, A., Barrandon, C., Byers, S. A., Searcey, C. E., Cooper, J. J., Bensaude, O., Cohen, E. A., Coulombe, B., Price, D. H. (2008). LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Res 36: 2219-2229 [Abstract] [Full Text]  
  • Fujita, T., Ryser, S., Piuz, I., Schlegel, W. (2008). Up-Regulation of P-TEFb by the MEK1-Extracellular Signal-Regulated Kinase Signaling Pathway Contributes to Stimulated Transcription Elongation of Immediate Early Genes in Neuroendocrine Cells. Mol. Cell. Biol. 28: 1630-1643 [Abstract] [Full Text]  
  • Luscher-Firzlaff, J., Gawlista, I., Vervoorts, J., Kapelle, K., Braunschweig, T., Walsemann, G., Rodgarkia-Schamberger, C., Schuchlautz, H., Dreschers, S., Kremmer, E., Lilischkis, R., Cerni, C., Wellmann, A., Luscher, B. (2008). The Human Trithorax Protein hASH2 Functions as an Oncoprotein. Cancer Res. 68: 749-758 [Abstract] [Full Text]  
  • Yang, Z., He, N., Zhou, Q. (2008). Brd4 Recruits P-TEFb to Chromosomes at Late Mitosis To Promote G1 Gene Expression and Cell Cycle Progression. Mol. Cell. Biol. 28: 967-976 [Abstract] [Full Text]  
  • Kim, Y., Kipreos, E. T. (2007). The Caenorhabditis elegans Replication Licensing Factor CDT-1 Is Targeted for Degradation by the CUL-4/DDB-1 Complex. Mol. Cell. Biol. 27: 1394-1406 [Abstract] [Full Text]  
  • Meier, N., Krpic, S., Rodriguez, P., Strouboulis, J., Monti, M., Krijgsveld, J., Gering, M., Patient, R., Hostert, A., Grosveld, F. (2006). Novel binding partners of Ldb1 are required for haematopoietic development. Development 133: 4913-4923 [Abstract] [Full Text]  
  • Lee, H., Zeng, S. X., Lu, H. (2006). UV Induces p21 Rapid Turnover Independently of Ubiquitin and Skp2. J. Biol. Chem. 281: 26876-26883 [Abstract] [Full Text]  
  • Zhou, Q., Yik, J. H. N. (2006). The Yin and Yang of P-TEFb Regulation: Implications for Human Immunodeficiency Virus Gene Expression and Global Control of Cell Growth and Differentiation. Microbiol. Mol. Biol. Rev. 70: 646-659 [Abstract] [Full Text]  
  • Cai, D., Byth, K. F., Shapiro, G. I. (2006). AZ703, an Imidazo[1,2-a]Pyridine Inhibitor of Cyclin-Dependent Kinases 1 and 2, Induces E2F-1-Dependent Apoptosis Enhanced by Depletion of Cyclin-Dependent Kinase 9. Cancer Res. 66: 435-444 [Abstract] [Full Text]  
  • Marshall, R. M., Salerno, D., Garriga, J., Grana, X. (2005). Cyclin T1 Expression Is Regulated by Multiple Signaling Pathways and Mechanisms during Activation of Human Peripheral Blood Lymphocytes. J. Immunol. 175: 6402-6411 [Abstract] [Full Text]  
  • Barboric, M., Zhang, F., Besenicar, M., Plemenitas, A., Peterlin, B. M. (2005). Ubiquitylation of Cdk9 by Skp2 Facilitates Optimal Tat Transactivation. J. Virol. 79: 11135-11141 [Abstract] [Full Text]  
  • Schulte, A., Czudnochowski, N., Barboric, M., Schonichen, A., Blazek, D., Peterlin, B. M., Geyer, M. (2005). Identification of a Cyclin T-Binding Domain in Hexim1 and Biochemical Analysis of Its Binding Competition with HIV-1 Tat. J. Biol. Chem. 280: 24968-24977 [Abstract] [Full Text]  
  • Liou, L.-Y., Herrmann, C. H., Rice, A. P. (2004). Human Immunodeficiency Virus Type 1 Infection Induces Cyclin T1 Expression in Macrophages. J. Virol. 78: 8114-8119 [Abstract] [Full Text]  
  • Yik, J. H. N., Chen, R., Pezda, A. C., Samford, C. S., Zhou, Q. (2004). A Human Immunodeficiency Virus Type 1 Tat-Like Arginine-Rich RNA-Binding Domain Is Essential for HEXIM1 To Inhibit RNA Polymerase II Transcription through 7SK snRNA-Mediated Inactivation of P-TEFb. Mol. Cell. Biol. 24: 5094-5105 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»